Eli Lilly and Company - Interest Expense

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Millions.

The item "Interest-Expense" stands at 897.00 Million United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.

Eli Lilly and Company's third quarter result of 179.60 Million USD for the item "Interest Expense" represents a decrease of -27.87 percent compared to it's second quarter result.

Also, Eli Lilly and Company's third quarter result of 179.60 Million USD for the item "Interest Expense" represents a decrease of -6.80 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Eli Lilly and Company's third quarter result of 897.00 Million USD for the item "Interest Expense" represents a decrease of -1.44 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 29.23 percent compared to the value the year prior.
The 1 year change in percent is 29.23.
The 3 year change in percent is 172.64.
The 5 year change in percent is 144.88.
The 10 year change in percent is 480.96.

The Serie's long term average value is 320.69 Million United States Dollars. It's latest available value, on 09/30/2025, is 179.71 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2014, to it's latest available value, on 09/30/2025, is +502.82%.
The Serie's change in percent from it's maximum value, on 06/30/2025, to it's latest available value, on 09/30/2025, is -1.44%.